The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

Researchers developed a wearable jumpsuit with sensors that can objectively measure an infant’s gross motor development and, ...

In patients who have previously undergone corneal refractive surgery, the asymmetric segmental design of the Acunex VarioMax ...

One question that freshly matriculated medical students become well-versed in answering is “what specialty are you interested in?”I answered that question hundreds of times with an ever-evolving ...

Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Cataracts are the leading cause of blindness in adults older than age 50 worldwide.The global prevalence of cataracts has ...

As cornea specialists, we talk a lot about how to get timely referrals of keratoconus patients from optometrists and ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

The American Academy of Dermatology has created a measles resource center for dermatologists to stay prepared during the current U.S. measles outbreak. Created by the AAD’s Emerging Diseases Task ...

The use of technicians to assist in delivering dialysis to the end-stage kidney disease population has been a recognized role ...

A remote monitoring program predicted when patients with asthma would experience distress, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy ...